Characterization of the population that consults by epistaxis to the Otolaryngology Service of the Hospital Universitario Mayor Méderi (HUM)

Main Article Content

Liliana Isabel Alfaro Arias
Mary Lourdes Hernández López
Jose Alejandro Daza Vergara

Abstract

Introduction: Epistaxis is one of the main reasons for emergency consultation in the Otolaryngology department. Most episodes originate in the anterior nasal septum and their management tends to be conservative. Objective: To characterize the population that consults for epistaxis at the Otolaryngology service of the Hospital Universitario Mayor Méderi (HUM) between March 2017 and February 2018. Methodology: Observational, descriptive, cross-sectional study, with retrospective data collection of patients admitted to the HUM emergency room for epistaxis, registered in the Otolaryngology service database. Demographic data, location of bleeding, treatment, comorbidities, drugs and blood pressure were analyzed.


 

Article Details

Section

Trabajos Originales

How to Cite

1.
Characterization of the population that consults by epistaxis to the Otolaryngology Service of the Hospital Universitario Mayor Méderi (HUM). Acta otorrinolaringol cir cabeza cuello [Internet]. 2020 Sep. 30 [cited 2025 Dec. 26];48(3):232-8. Available from: https://www.revista.acorl.org.co/index.php/acorl/article/view/493

References

1. Bequignon E, Vérillaud B, Robard L, Michel J, Prulière Escabasse V, Crampette L, et al. Guidelines of the French Society of Otorhinolaryngology (SFORL). First-line treatment of epistaxis in adults. Eur Ann Otorhinolaryngol Head Neck Dis. 2017;134(3):185-9. doi:10.1016/j.anorl.2016.09.008

2. Al-bar MH. Epistaxis and catastrophic nasal bleeding. OperTech Otolaryngol - Head Neck Surg. 2014;25(2):194-200. doi:10.1016/j.otot.2014.02.010

3. Davies K, Batra K, Mehanna R, Keogh I. Pediatric epistaxis:epidemiology, management & impact on quality of life. Int JPediatr Otorhinolaryngol. 2014;78(8):1294-97. doi:10.1016/j.ijporl.2014.05.013

4. Kasperek ZA, Pollock GF. Epistaxis: an overview. Emerg Med Clin North Am. 2013;31(2):443-454. doi:10.1016/j.emc.2013.01.008

5. Kindler RM, Holzmann D, Landis BN, Ditzen B, Soyka MB. The high rate of long-term recurrences and sequelae after epistaxis treatment. Auris Nasus Larynx. 2016;43(4):412-7.doi:10.1016/j.anl.2015.09.011

6. Verillaud B, Robard L, Michel J, Pruliere Escabasse V, Béquignon E, et al. Guidelines of the French Society of Otorhinolaryngology (SFORL). Second-line treatment ofepistaxis in adults. Eur Ann Otorhinolaryngol Head Neck Dis.2017;134(3):191-193. doi:10.1016/j.anorl.2016.09.009

7. Lin G, Bleier B. Surgical Management of Severe Epistaxis.Otolaryngol Clin North Am. 2016;49(3):627-37. doi:10.1016/j.otc.2016.01.003

8. Monjas-Cánovas I, Hernández-García I, Mauri-Barberá J, Sanz- Romero B, Gras-Albert JR. Epidemiología de las epistaxisingresadas en un hospital de tercer nivel. Acta OtorrinolaringolEsp. 2010;61(1):41–7.

9. Pallin DJ, Chng YM, McKay MP, Emond JA, Pelletier AJ,Camargo CA Jr. Epidemiology of epistaxis in US emergency departments, 1992 to 2001. Ann Emerg Med. 2005;46(1):77-81.doi:10.1016/j.annemergmed.2004.12.014

10. Viehweg TL, Roberson JB, Hudson JW. Epistaxis: diagnosis and treatment. J Oral Maxillofac Surg. 2006;64(3):511-518.doi:10.1016/j.joms.2005.11.031

11. Ando Y, Iimura J, Arai S, et al. Risk factors for recurrent epistaxis: importance of initial treatment. Auris Nasus Larynx.2014;41(1):41-45. doi:10.1016/j.anl.2013.05.004

12. Corr MJ, Tikka T, Douglas CM, Marshall J. One-year all-cause mortality for 338 patients admitted with epistaxis in a largetertiary ENT centre. J Laryngol Otol. 2019;133(6):487-493.doi:10.1017/S0022215119000860

13. Newton E, Lasso A, Petrcich W, Kilty SJ. An outcomes analysis of anterior epistaxis management in the emergency department. J Otolaryngol Head Neck Surg. 2016;45:24. doi:10.1186/s40463-016-0138-2

14. Kubba H, MacAndie C, Botma M, et al. A prospective, singleblind, randomized controlled trial of antiseptic cream for recurrent epistaxis in childhood. Clin Otolaryngol Allied Sci.2001;26(6):465-468. doi:10.1046/j.1365-2273.2001.00502.x

15. Abrich V, Brozek A, Boyle TR, Chyou PH, Yale SH. Risk factors for recurrent spontaneous epistaxis. Mayo Clin Proc. Acta de Otorrinolaringología & Cirugía de Cabeza y Cuello. 2020; 48(3): 44(2): 92-99 33 2014;89(12):1636-1643. doi:10.1016/j.mayocp.2014.09.009

16. Terakura M, Fujisaki R, Suda T, Sagawa T, Sakamoto T.Relationship between blood pressure and persistent epistaxis at the emergency department: a retrospective study. J Am Soc Hypertens. 2012;6(4):291-295. doi:10.1016/j.jash.2012.05.001

17. Lubianca Neto JF, Fuchs FD, Facco SR, et al. Is epistaxis evidence of end-organ damage in patients with hypertension?. Laryngoscope. 1999;109(7 Pt 1):1111-15.doi:10.1097/00005537-199907000-00019

18. Min HJ, Kang H, Choi GJ, Kim KS. Association between Hypertension and Epistaxis: Systematic Review and Metaanalysis. Otolaryngol Head Neck Surg. 2017;157(6):921-927.doi:10.1177/0194599817721445

Most read articles by the same author(s)